Last updated on November 2019

Tepotinib Phase II in Non-small Cell Lung Cancer (NSCLC) Harboring MET Alterations


Find a site near you

Start Over
Sorry. There are no research sites conducting this study in the radius provided. ( View all Sites )
If you would like to be informed of other studies that may be of interest to you, you may sign up for CenterWatch.com's Patient Notification Service. ( Sign Up )